Inventor · disambiguated record
Erich Rajkovic
Also filed as: RAJKOVIC ERICH
10 granted patents·3 pending applications·41 citations·filing 2015–2024
85Inventor score
Top patents by PatentIndex Score
13 records- 0192US9212225B1Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Dec 15, 2015·17 cites·14 claims
- 0290US9803029B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2015·Granted Oct 31, 2017·11 cites·18 claims
- 0388US10626190B2Bispecific CD33 and CD3 binding proteinsAMPHIVENA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·3 cites·12 claims
- 0487US11535672B2Combination of an anti-CD16A antibody with a cytokineAFFIMED GMBH·Filed 2019·Granted Dec 27, 2022·8 cites·28 claims
- 0582US11510972B2Bispecific EGFR/CD16 antigen-binding proteinAFFIMED GMBH·Filed 2020·Granted Nov 29, 2022·1 cites·16 claims
- 0679US11001633B2NK cell engaging antibody fusion constructsAFFIMED GMBH·Filed 2019·Granted May 11, 2021·1 cites·14 claims
- 0778US2024294647A1Uses of nk cell engaging antibody fusion constructs for treatmentsAFFIMED GMBH·Filed 2024·Application pending·0 cites
- 0873US12076384B2Bispecific EGFR/CD16 antigen-binding proteinAFFIMED GMBH·Filed 2022·Granted Sep 3, 2024·0 cites·17 claims
- 0966US2021253698A1Uses of nk cell engaging antibody fusion constructs for treatmentsAFFIMED GMBH·Filed 2021·Application pending·0 cites
- 1065US12264198B2Tandem diabody for CD16A-directed NK-cell engagementAFFIMED GMBH·Filed 2021·Granted Apr 1, 2025·0 cites·11 claims
- 1165US2021024654A1Bispecific CD33 and CD3 Binding ProteinsAMPHIVENA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1260US11180558B2Tandem diabody for CD16A-directed NK-cell engagementAFFIMED GMBH·Filed 2019·Granted Nov 23, 2021·0 cites·11 claims
- 1344US11572415B2Multivalent FV antibodiesAFFIMED GMBH·Filed 2018·Granted Feb 7, 2023·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Erich Rajkovic files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →